Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2004-8-23
pubmed:abstractText
Attention-deficit/hyperactivity disorder (AD/HD) is a common pediatric behavioral disorder associated, in part, with male preponderance and reduced regional cerebral blood flow (rCBF). However, mechanism(s) underlying male preponderance and reduced rCBF in AD/HD are unclear. The present study profiles the expression of angiogenic and hormonal factors likely to underlie these symptoms using a recently characterized AD/HD animal model, juvenile male stroke-prone spontaneously hypertensive rats (SHRSP). Because vascular endothelial growth factor (VEGF) signaling cascade and gonadal steroids are key regulators of angiogenesis and gender-based behavior, respectively, we profiled their patterns of expression in the frontal cortex of SHRSP to elucidate their roles in the genesis of AD/HD male preponderance and rCBF. Interestingly, levels of VEGF, VEGF receptors (KDR, Flt-1), endothelial nitric oxide synthase, phosphorylated Akt (pAkt), estrogen receptor-alpha, aromatase, and capillary density in sham-operated SHRSP were remarkably down-regulated, whereas androgen receptor levels were up-regulated, compared with age-matched genetic control, Wistar-Kyoto rats. Castration, estrogen, and androgen receptor antagonist (flutamide) counteracted these effects. Dihydrotestosterone, but not testosterone, reversed the beneficiary effects of castration. Estrogen receptor-beta levels remained unchanged in all groups examined. We postulate that changes in androgen metabolism that tend to up-regulate local dihydrotestosterone concentration and diminish estrogen synthesis, in the frontal cortex of juvenile male SHRSP, may lower levels and/or activity of VEGF and its signaling cascade and, subsequently, reduce rCBF. These findings could, in part, help explain the pathogenesis of reduced rCBF and male preponderance in AD/HD.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Akt1 protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/Aromatase, http://linkedlifedata.com/resource/pubmed/chemical/Dihydrotestosterone, http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Receptor alpha, http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Receptor beta, http://linkedlifedata.com/resource/pubmed/chemical/Estrogens, http://linkedlifedata.com/resource/pubmed/chemical/Gonadal Steroid Hormones, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase Type III, http://linkedlifedata.com/resource/pubmed/chemical/Nos3 protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/Protein-Serine-Threonine Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-akt, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Androgen, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen, http://linkedlifedata.com/resource/pubmed/chemical/Testosterone, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor..., http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor...
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0013-7227
pubmed:author
pubmed:issnType
Print
pubmed:volume
145
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4330-43
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:15178644-Animals, pubmed-meshheading:15178644-Aromatase, pubmed-meshheading:15178644-Attention Deficit Disorder with Hyperactivity, pubmed-meshheading:15178644-Capillaries, pubmed-meshheading:15178644-Cerebrovascular Circulation, pubmed-meshheading:15178644-Dihydrotestosterone, pubmed-meshheading:15178644-Disease Models, Animal, pubmed-meshheading:15178644-Estrogen Receptor alpha, pubmed-meshheading:15178644-Estrogen Receptor beta, pubmed-meshheading:15178644-Estrogens, pubmed-meshheading:15178644-Frontal Lobe, pubmed-meshheading:15178644-Gonadal Steroid Hormones, pubmed-meshheading:15178644-Hypertension, pubmed-meshheading:15178644-Male, pubmed-meshheading:15178644-Nitric Oxide, pubmed-meshheading:15178644-Nitric Oxide Synthase, pubmed-meshheading:15178644-Nitric Oxide Synthase Type III, pubmed-meshheading:15178644-Protein-Serine-Threonine Kinases, pubmed-meshheading:15178644-Proto-Oncogene Proteins, pubmed-meshheading:15178644-Proto-Oncogene Proteins c-akt, pubmed-meshheading:15178644-Rats, pubmed-meshheading:15178644-Rats, Inbred SHR, pubmed-meshheading:15178644-Rats, Inbred WKY, pubmed-meshheading:15178644-Receptors, Androgen, pubmed-meshheading:15178644-Receptors, Estrogen, pubmed-meshheading:15178644-Signal Transduction, pubmed-meshheading:15178644-Stroke, pubmed-meshheading:15178644-Testosterone, pubmed-meshheading:15178644-Vascular Endothelial Growth Factor A, pubmed-meshheading:15178644-Vascular Endothelial Growth Factor Receptor-1, pubmed-meshheading:15178644-Vascular Endothelial Growth Factor Receptor-2
pubmed:year
2004
pubmed:articleTitle
Gonadal hormones and frontocortical expression of vascular endothelial growth factor in male stroke-prone, spontaneously hypertensive rats, a model for attention-deficit/hyperactivity disorder.
pubmed:affiliation
Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine, Sapporo 060-8638, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't